A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01108653|
Recruitment Status : Unknown
Verified January 2010 by Oslo University Hospital.
Recruitment status was: Recruiting
First Posted : April 22, 2010
Last Update Posted : May 7, 2010
|Condition or disease||Intervention/treatment||Phase|
|Myocardial Infarction||Other: Usual care sick-leave management Other: Structuralised sick-leave program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction|
|Study Start Date :||January 2010|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2012|
|Group 1: Usual care sick-leave management||
Other: Usual care sick-leave management
Patients randomized to usual care. Follow up after discharge by general practitioner (GP) according to local practice.
|Group 2: Structuralised sick-leave program||
Other: Structuralised sick-leave program
Patients randomized to the structuralized program will get full time sick-leave for 2 weeks after discharge.Cardiologist will be responsible for individual adaption of each patient`s sick-leave and follow-up.
- Cost effectiveness [ Time Frame: one year ]In order to evaluate resource use (costs) all patients will be asked to fill in a questionnaire at baseline and after 6 and 12 months. Total costs and mean costs will be calculated in the two different follow-up modalities.
- Quality of Life measures are estimated at baseline and after 6 and 12 months using the standard Medical Outcomes Study Short form( SF-36)questionnaire and the disease-specific Utility-Based Quality of life-Heart questionnaire(UBQ-H). [ Time Frame: one year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01108653
|Contact: Stefan Agewall, Professor, MD.PhDfirstname.lastname@example.org|
|Contact: Liv Mundal, MDemail@example.com|
|Oslo University Hospital||Recruiting|
|Oslo, Trondheimsveien 235, Norway, 0514|
|Principal Investigator: Stefan Agewall, Professor|
|Principal Investigator:||Stefan Agewall, Professor||Oslo University Hospital. Department of Cardiology. Trondheimsveien 235, 0514 Oslo, Norway|